NCT00006218View on ClinicalTrials.gov

3-AP in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2000

Study Completion Date

January 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

triapine

Trial Locations (1)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00006218 - 3-AP in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter